187 related articles for article (PubMed ID: 14615147)
61. An inactivated vaccine from a field strain of bovine herpesvirus-1 (BoHV-1) has high antigenic mass and induces strong efficacy in a rabbit model.
Ruiz-Sáenz J; Jaime J; Vera V
Virol Sin; 2013 Feb; 28(1):36-42. PubMed ID: 23385353
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of BHV-1 antibody titer in a cattle herd against different BHV-1 strains.
Lee M; Reed A; Estill C; Izume S; Dong J; Jin L
Vet Microbiol; 2015 Sep; 179(3-4):228-32. PubMed ID: 26123370
[TBL] [Abstract][Full Text] [Related]
63. Vaccination trials against bovine herpesvirus-1.
Castrucci G; Ferrari M; Salvatori D; Sardonini S; Frigeri F; Petrini S; Lo Dico M; Marchini C; Rotola A; Amici A; Provinciali M; Tosini A; Angelini R; Cassai E
Vet Res Commun; 2005 Aug; 29 Suppl 2():229-31. PubMed ID: 16244962
[No Abstract] [Full Text] [Related]
64. BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response.
Gao Y; Daley MJ; Splitter GA
Vaccine; 1995 Jun; 13(9):871-7. PubMed ID: 7483811
[TBL] [Abstract][Full Text] [Related]
65. Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine.
Kerkhofs P; Renjifo X; Toussaint JF; Letellier C; Vanopdenbosch E; Wellemans G
Vet Rec; 2003 May; 152(22):681-6. PubMed ID: 12803395
[TBL] [Abstract][Full Text] [Related]
66. Effectiveness of a BHV-1/BEFV bivalent vaccine against bovine herpesvirus type 1 infection in cattle.
Chung YC; Shen HY; Cheng LT; Liu SS; Chu CY
Res Vet Sci; 2016 Dec; 109():161-165. PubMed ID: 27892866
[TBL] [Abstract][Full Text] [Related]
67. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
[TBL] [Abstract][Full Text] [Related]
68. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.
Gogev S; de Fays K; Versali MF; Gautier S; Thiry E
Vaccine; 2004 May; 22(15-16):1946-53. PubMed ID: 15121307
[TBL] [Abstract][Full Text] [Related]
69. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.
DesCôteaux L; Cécyre D; Elsener J; Beauchamp G
Can Vet J; 2003 Oct; 44(10):816-21. PubMed ID: 14601677
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study.
Ficken MD; Ellsworth MA; Tucker CM
Vet Ther; 2006; 7(3):275-82. PubMed ID: 17039450
[TBL] [Abstract][Full Text] [Related]
71. A live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine induces a partial cross-protection against caprine herpesvirus 1 infection in goats.
Thiry J; Tempesta M; Camero M; Tarsitano E; Bellacicco AL; Thiry E; Buonavoglia C
Vet Microbiol; 2006 Mar; 113(3-4):303-8. PubMed ID: 16330168
[TBL] [Abstract][Full Text] [Related]
72. Bovine herpesvirus type 1 marker vaccine induces cross-protection against bubaline herpesvirus type 1 in water buffalo.
Montagnaro S; De Martinis C; Iovane V; Ciarcia R; Damiano S; Nizza S; De Martino L; Iovane G; Pagnini U
Prev Vet Med; 2014 Sep; 116(1-2):56-62. PubMed ID: 24985155
[TBL] [Abstract][Full Text] [Related]
73. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
Patel JR; Shilleto RW
Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
[TBL] [Abstract][Full Text] [Related]
74. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
[TBL] [Abstract][Full Text] [Related]
75. Bovine herpes virus infections in cattle.
Nandi S; Kumar M; Manohar M; Chauhan RS
Anim Health Res Rev; 2009 Jun; 10(1):85-98. PubMed ID: 19558751
[TBL] [Abstract][Full Text] [Related]
76. Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity.
Pérez Filgueira DM; Zamorano PI; Domínguez MG; Taboga O; Del Médico Zajac MP; Puntel M; Romera SA; Morris TJ; Borca MV; Sadir AM
Vaccine; 2003 Oct; 21(27-30):4201-9. PubMed ID: 14505899
[TBL] [Abstract][Full Text] [Related]
77. Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency.
Lemaire M; Weynants V; Godfroid J; Schynts F; Meyer G; Letesson JJ; Thiry E
J Clin Microbiol; 2000 May; 38(5):1885-94. PubMed ID: 10790117
[TBL] [Abstract][Full Text] [Related]
78. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
[TBL] [Abstract][Full Text] [Related]
79. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
[TBL] [Abstract][Full Text] [Related]
80. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
Wei H; He J; Paulsen DB; Chowdhury SI
Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
